Conference abstractPublished 14 Mar 2022
Assessment of myeloperoxidase levels in elderly patients with type 2 diabetes mellitus
National Institute of Gerontology and Geriatrics Bucharest, Romania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Diabetes is a chronic condition that results in excessive blood sugar circulation, which can lead to disorders of the circulatory, nervous, and immune systems. Many studies have shown that myeloperoxidase (MPO), a heme protein released by leukocytes, is involved in the process of oxidative stress and plays an important role in the initiation and progression of acute and chronic inflammatory diseases, suggesting a positive correlation between activation of MPO and metabolic disorders. Purpose: Our study was proposed to assess levels of myeloperoxidase in two groups of elderly patients (69.15 ± 7.33 years): a group of control patients and a group of patients with type 2 diabetes. Methods: MPO levels were determined in serum by immunoenzymatic assay and spectrophotometric detection at 450 nm. Results: In this study, serum MPO concentration was demonstrated to be significantly higher in diabetic patients compared with non-diabetic group (625 ± 252.83 vs 436.66 ± 89.62 ng / ml serum). Conclusions: In conclusion, patients with type 2 diabetes had increased serum MPO levels, wich proves that MPO, being an pro-inflammatory enzyme, can be considered an early biomarker and indicator for inflammation associated with metabolic disorders in diabetic patients.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Gianina Ioana Constantin”